ERAS
USDErasca Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.580
Kõrge
$1.615
Madal
$1.515
Maht
1.46M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
430.6M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
1.73M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Raymond James Initiates Coverage On Erasca with Outperform Rating, Announces Price Target of $5
Raymond James analyst Laura Prendergast initiates coverage on Erasca with a Outperform rating and announces Price Target of $5.
Erasca Announces Three Poster Presentations at the 2025 AACR Annual Meeting
Presentations will feature potential best-in-class pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Erasca will also present potential first-in-class examples of direct SMP complex inhibitors,
Goldman Sachs Maintains Buy on Erasca, Lowers Price Target to $3
Goldman Sachs analyst Chris Shibutani maintains Erasca with a Buy and lowers the price target from $3.5 to $3.
HC Wainwright & Co. Reiterates Buy on Erasca, Maintains $6 Price Target
HC Wainwright & Co. analyst Andres Maldonado reiterates Erasca with a Buy and maintains $6 price target.
Morgan Stanley Assumes Erasca at Overweight, Maintains Price Target of $4
Morgan Stanley analyst Jeffrey Hung assumes Erasca with a Overweight rating and maintains Price Target of $4.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.